EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Joint Society Statement From the Society for Endocrinology (SfE), the British Thyroid Association (BTA) and the British Association of Endocrine and Thyroid Surgeons (BAETS) Regarding the Association of GLP‐1 Agonists and Thyroid Cancer

Emma Watts iD, Jonathan Wadsley iD, Neil Sharma iD, Kristien Boelaert iD, UK Thyroid Cancer Study Group

Clinical Endocrinology · 2026-05 · 104 (5) · 507-509

DOI: 10.1111/cen.70084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, online erschienen am 21.12.2025. Verfasst von Emma Watts und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Queen Elizabeth Hospital Birmingham, Birmingham, UK. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Otolaryngology, Head and Neck Surgery, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
  • Department of Oncology, Weston Park Cancer Centre, Sheffield, UK.
  • Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Department of Endocrinology, Queen Elizabeth Hospital Birmingham, Birmingham, UK.

ORCID-Profile: Emma Watts, Jonathan Wadsley, Neil Sharma, Kristien Boelaert

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Watts, E., Wadsley, J., Sharma, N., Boelaert, K., & UK Thyroid Cancer Study Group (2026). Joint Society Statement From the Society for Endocrinology (SfE), the British Thyroid Association (BTA) and the British Association of Endocrine and Thyroid Surgeons (BAETS) Regarding the Association of GLP‐1 Agonists and Thyroid Cancer. Clinical Endocrinology, 104(5), 507-509. https://doi.org/10.1111/cen.70084

Vancouver

Watts E, Wadsley J, Sharma N, Boelaert K, UK Thyroid Cancer Study Group. Joint Society Statement From the Society for Endocrinology (SfE), the British Thyroid Association (BTA) and the British Association of Endocrine and Thyroid Surgeons (BAETS) Regarding the Association of GLP‐1 Agonists and Thyroid Cancer. Clinical Endocrinology. 2026;104(5):507-509. doi:10.1111/cen.70084

BibTeX
@article{Watts2026,
  author = {Watts, Emma and Wadsley, Jonathan and Sharma, Neil and Boelaert, Kristien and UK Thyroid Cancer Study Group, UK Thyroid Cancer Study Group},
  title = {Joint Society Statement From the Society for Endocrinology (SfE), the British Thyroid Association (BTA) and the British Association of Endocrine and Thyroid Surgeons (BAETS) Regarding the Association of GLP‐1 Agonists and Thyroid Cancer},
  journal = {Clinical Endocrinology},
  year = {2026},
  volume = {104},
  number = {5},
  pages = {507--509},
  doi = {10.1111/cen.70084}
}
Kostenlos starten →